QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (193) Citing Articles via Google Scholar Google Scholar Articles by Kotilinek, L. A. Articles by Ashe, K. H. Search for Related Content PubMed PubMed Citation Articles by Kotilinek, L. A. Articles by Ashe, K. H. Pubmed/NCBI databases Medline Plus Health Information Alzheimer's Disease Memory

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2002, 22(15):6331-6335

BRIEF COMMUNICATION
Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease

Linda A. Kotilinek¹, Brian Bacskai², Marcus Westerman¹, Takeshi Kawarabayashi³, Linda Younkin³, Bradley T. Hyman², Steven Younkin³, and Karen H. Ashe¹

¹ Departments of Neurology and Neuroscience, University of Minnesota, Minneapolis 55455, ² Department of Neurology, Massachusetts General Hospital East, Charlestown, Massachusetts 02129, and ³ Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224

Alzheimer's disease (AD) is a neurodegenerative condition, believed to be irreversible, characterized by inexorable deterioration of memory and intellect, with neuronal loss accompanying amyloid plaques and neurofibrillary tangles. In an amyloid precursor protein transgenic mouse model, Tg2576, little or no neuronal loss accompanies age-related memory impairment or the accumulation of A, a 40-42 aa polypeptide found in plaques. Recently, we have shown inverse correlations between brain A and memory in Tg2576 mice stratified by age (Westerman et al., 2002). Broadening the age range examined obscured this relationship, leading us to propose that small, soluble assemblies of A disrupt cognitive function in these mice. Here we show that memory loss can be fully reversed in Tg2576 mice using intraperitoneally administered BAM-10, a monoclonal antibody recognizing the N terminus of A. The beneficial effect of BAM-10 was not associated with a significant A reduction, but instead eliminated the inverse relationship between brain A and memory. We postulate that BAM-10 acts by neutralizing A assemblies in the brain that impair cognitive function. Our results indicate that a substantial portion of memory loss in Tg2576 mice is not permanent. If these A assemblies contribute significantly to memory loss in AD, then successfully targeting them might improve memory in some AD patients.

Key words: Alzheimer's disease; transgenic; behavior; A; monoclonal antibodies; memory

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22156331-05$05.00/0

This article has been cited by other articles:

				J. C. Mitchell, B. B. Ariff, D. M. Yates, K.-F. Lau, M. S. Perkinton, B. Rogelj, J. D. Stephenson, C. C.J. Miller, and D. M. McLoughlin X11{beta} rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice Hum. Mol. Genet., December 1, 2009; 18(23): 4492 - 4500. [Abstract] [Full Text] [PDF]

				K. Yamada, C. Yabuki, P. Seubert, D. Schenk, Y. Hori, S. Ohtsuki, T. Terasaki, T. Hashimoto, and T. Iwatsubo A{beta} Immunotherapy: Intracerebral Sequestration of A{beta} by an Anti-A{beta} Monoclonal Antibody 266 with High Affinity to Soluble A{beta} J. Neurosci., September 9, 2009; 29(36): 11393 - 11398. [Abstract] [Full Text] [PDF]

				P. Bach, J.-A. Tschape, F. Kopietz, G. Braun, J. K. Baade, K.-H. Wiederhold, M. Staufenbiel, M. Prinz, T. Deller, U. Kalinke, et al. Vaccination with A{beta}-Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral A{beta} and Lowers Plaque Burden in APP Transgenic Mice J. Immunol., June 15, 2009; 182(12): 7613 - 7624. [Abstract] [Full Text] [PDF]

				J. C. Diaz, O. Simakova, K. A. Jacobson, N. Arispe, and H. B. Pollard From the Cover: Small molecule blockers of the Alzheimer A{beta} calcium channel potently protect neurons from A{beta} cytotoxicity PNAS, March 3, 2009; 106(9): 3348 - 3353. [Abstract] [Full Text] [PDF]

				K. Nishitsuji, T. Tomiyama, K. Ishibashi, K. Ito, R. Teraoka, M. P. Lambert, W. L. Klein, and H. Mori The E693{Delta} Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid {beta} Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells Am. J. Pathol., March 1, 2009; 174(3): 957 - 969. [Abstract] [Full Text] [PDF]

				F. Cacucci, M. Yi, T. J. Wills, P. Chapman, and J. O'Keefe Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model PNAS, June 3, 2008; 105(22): 7863 - 7868. [Abstract] [Full Text] [PDF]

				K. L. Richard, M. Filali, P. Prefontaine, and S. Rivest Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid {beta}1-42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease J. Neurosci., May 28, 2008; 28(22): 5784 - 5793. [Abstract] [Full Text] [PDF]

				I. Klyubin, V. Betts, A. T. Welzel, K. Blennow, H. Zetterberg, A. Wallin, C. A. Lemere, W. K. Cullen, Y. Peng, T. Wisniewski, et al. Amyloid {beta} Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization J. Neurosci., April 16, 2008; 28(16): 4231 - 4237. [Abstract] [Full Text] [PDF]

				E. Head, V. Pop, V. Vasilevko, M. Hill, T. Saing, F. Sarsoza, M. Nistor, L.-A. Christie, S. Milton, C. Glabe, et al. A Two-Year Study with Fibrillar {beta}-Amyloid (A{beta}) Immunization in Aged Canines: Effects on Cognitive Function and Brain A{beta} J. Neurosci., April 2, 2008; 28(14): 3555 - 3566. [Abstract] [Full Text] [PDF]

				T. Yoshihara, S. Takiguchi, A. Kyuno, K. Tanaka, S. Kuba, S. Hashiguchi, Y. Ito, T. Hashimoto, T. Iwatsubo, S. Tsuyama, et al. Immunoreactivity of Phage Library-derived Human Single-Chain Antibodies to Amyloid Beta Conformers In Vitro J. Biochem., April 1, 2008; 143(4): 475 - 486. [Abstract] [Full Text] [PDF]

				L. A. Kotilinek, M. A. Westerman, Q. Wang, K. Panizzon, G. P. Lim, A. Simonyi, S. Lesne, A. Falinska, L. H. Younkin, S. G. Younkin, et al. Cyclooxygenase-2 inhibition improves amyloid-{beta}-mediated suppression of memory and synaptic plasticity Brain, March 1, 2008; 131(3): 651 - 664. [Abstract] [Full Text] [PDF]

				S. Petratos, Q.-X. Li, A. J. George, X. Hou, M. L. Kerr, S. E. Unabia, I. Hatzinisiriou, D. Maksel, M.-I. Aguilar, and D. H. Small The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism Brain, January 1, 2008; 131(1): 90 - 108. [Abstract] [Full Text] [PDF]

				D. Tampellini, J. Magrane, R. H. Takahashi, F. Li, M. T. Lin, C. G. Almeida, and G. K. Gouras Internalized Antibodies to the Abeta Domain of APP Reduce Neuronal Abeta and Protect against Synaptic Alterations J. Biol. Chem., June 29, 2007; 282(26): 18895 - 18906. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, T. Gurlo, R. Kayed, A. E. Butler, L. Haataja, C. G. Glabe, and P. C. Butler Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP-Induced {beta}-Cell Apoptosis in h-IAPP Transgenic Mice Diabetes, May 1, 2007; 56(5): 1324 - 1332. [Abstract] [Full Text] [PDF]

				G. Chen, K. S. Chen, D. Kobayashi, R. Barbour, R. Motter, D. Games, S. J. Martin, and R. G. M. Morris Active {beta}-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of {beta}-Amyloid J. Neurosci., March 7, 2007; 27(10): 2654 - 2662. [Abstract] [Full Text] [PDF]

				C. M. Prada, M. Garcia-Alloza, R. A. Betensky, S. X. Zhang-Nunes, S. M. Greenberg, B. J. Bacskai, and M. P. Frosch Antibody-Mediated Clearance of Amyloid-{beta} Peptide from Cerebral Amyloid Angiopathy Revealed by Quantitative In Vivo Imaging J. Neurosci., February 21, 2007; 27(8): 1973 - 1980. [Abstract] [Full Text] [PDF]

				C. R. Jack Jr, M. Marjanska, T. M. Wengenack, D. A. Reyes, G. L. Curran, J. Lin, G. M. Preboske, J. F. Poduslo, and M. Garwood Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research Neuroscientist, February 1, 2007; 13(1): 38 - 48. [Abstract] [PDF]

				P. N. Lacor, M. C. Buniel, P. W. Furlow, A. Sanz Clemente, P. T. Velasco, M. Wood, K. L. Viola, and W. L. Klein A{beta} Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease J. Neurosci., January 24, 2007; 27(4): 796 - 807. [Abstract] [Full Text] [PDF]

				J. T. Ting, B. G. Kelley, T. J. Lambert, D. G. Cook, and J. M. Sullivan Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms PNAS, January 2, 2007; 104(1): 353 - 358. [Abstract] [Full Text] [PDF]

				M. J. Saganich, B. E. Schroeder, V. Galvan, D. E. Bredesen, E. H. Koo, and S. F. Heinemann Deficits in Synaptic Transmission and Learning in Amyloid Precursor Protein (APP) Transgenic Mice Require C-Terminal Cleavage of APP J. Neurosci., December 27, 2006; 26(52): 13428 - 13436. [Abstract] [Full Text] [PDF]

				S. Oddo, V. Vasilevko, A. Caccamo, M. Kitazawa, D. H. Cribbs, and F. M. LaFerla Reduction of Soluble Abeta and Tau, but Not Soluble Abeta Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles J. Biol. Chem., December 22, 2006; 281(51): 39413 - 39423. [Abstract] [Full Text] [PDF]

				H.-W. Klafki, M. Staufenbiel, J. Kornhuber, and J. Wiltfang Therapeutic approaches to Alzheimer's disease Brain, November 1, 2006; 129(11): 2840 - 2855. [Abstract] [Full Text] [PDF]

				R. L. Patton, W. M. Kalback, C. L. Esh, T. A. Kokjohn, G. D. Van Vickle, D. C. Luehrs, Y.-M. Kuo, J. Lopez, D. Brune, I. Ferrer, et al. Amyloid-{beta} Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis Am. J. Pathol., September 1, 2006; 169(3): 1048 - 1063. [Abstract] [Full Text] [PDF]

				D. M. Wilcock, J. Alamed, P. E. Gottschall, J. Grimm, A. Rosenthal, J. Pons, V. Ronan, K. Symmonds, M. N. Gordon, and D. Morgan Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J. Neurosci., May 17, 2006; 26(20): 5340 - 5346. [Abstract] [Full Text] [PDF]

				E. B. Lee, L. Z. Leng, B. Zhang, L. Kwong, J. Q. Trojanowski, T. Abel, and V. M.-Y. Lee Targeting Amyloid-beta Peptide (Abeta) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Abeta Precursor Protein (APP) Transgenic Mice J. Biol. Chem., February 17, 2006; 281(7): 4292 - 4299. [Abstract] [Full Text] [PDF]

				T. A. Comery, R. L. Martone, S. Aschmies, K. P. Atchison, G. Diamantidis, X. Gong, H. Zhou, A. F. Kreft, M. N. Pangalos, J. Sonnenberg-Reines, et al. Acute {gamma}-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease J. Neurosci., September 28, 2005; 25(39): 8898 - 8902. [Abstract] [Full Text] [PDF]

				R. E. Hartman, Y. Izumi, K. R. Bales, S. M. Paul, D. F. Wozniak, and D. M. Holtzman Treatment with an Amyloid-{beta} Antibody Ameliorates Plaque Load, Learning Deficits, and Hippocampal Long-Term Potentiation in a Mouse Model of Alzheimer's Disease J. Neurosci., June 29, 2005; 25(26): 6213 - 6220. [Abstract] [Full Text] [PDF]

				C. D. Keating Nanoscience enables ultrasensitive detection of Alzheimer's biomarker PNAS, February 15, 2005; 102(7): 2263 - 2264. [Full Text] [PDF]

				S. Tsuji DNA Vaccination May Open Up a New Avenue for Treatment of Alzheimer Disease Arch Neurol, December 1, 2004; 61(12): 1832 - 1832. [Full Text] [PDF]

				B. Qu, R. N. Rosenberg, L. Li, P. J. Boyer, and S. A. Johnston Gene Vaccination to Bias the Immune Response to Amyloid-{beta} Peptide as Therapy for Alzheimer Disease Arch Neurol, December 1, 2004; 61(12): 1859 - 1864. [Abstract] [Full Text] [PDF]

				P. N. Lacor, M. C. Buniel, L. Chang, S. J. Fernandez, Y. Gong, K. L. Viola, M. P. Lambert, P. T. Velasco, E. H. Bigio, C. E. Finch, et al. Synaptic Targeting by Alzheimer's-Related Amyloid {beta} Oligomers J. Neurosci., November 10, 2004; 24(45): 10191 - 10200. [Abstract] [Full Text] [PDF]

				K. Herrup, R. Neve, S. L. Ackerman, and A. Copani Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death J. Neurosci., October 20, 2004; 24(42): 9232 - 9239. [Full Text] [PDF]

				D. S. Gelinas, K. DaSilva, D. Fenili, P. St. George-Hyslop, and J. McLaurin Immunotherapy for Alzheimer's disease PNAS, October 5, 2004; 101(suppl_2): 14657 - 14662. [Abstract] [Full Text] [PDF]

				J. Krezowski, D. Knudson, C. Ebeling, R. Pitstick, R. K. Giri, D. Schenk, D. Westaway, L. Younkin, S. G. Younkin, K. H. Ashe, et al. Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression Hum. Mol. Genet., September 15, 2004; 13(18): 1989 - 1997. [Abstract] [Full Text] [PDF]

				F. G. DE FELICE, M. N. N. VIEIRA, L. M. SARAIVA, J. D. FIGUEROA-VILLAR, J. GARCIA-ABREU, R. LIU, L. CHANG, W. L. KLEIN, and S. T. FERREIRA Targeting the neurotoxic species in Alzheimer's disease: inhibitors of A{beta} oligomerization FASEB J, September 1, 2004; 18(12): 1366 - 1372. [Abstract] [Full Text] [PDF]

				E. M. Sigurdsson, E. Knudsen, A. Asuni, C. Fitzer-Attas, D. Sage, D. Quartermain, F. Goni, B. Frangione, and T. Wisniewski An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-{beta} Derivatives J. Neurosci., July 14, 2004; 24(28): 6277 - 6282. [Abstract] [Full Text] [PDF]

				D. M. Wilcock, A. Rojiani, A. Rosenthal, G. Levkowitz, S. Subbarao, J. Alamed, D. Wilson, N. Wilson, M. J. Freeman, M. N. Gordon, et al. Passive Amyloid Immunotherapy Clears Amyloid and Transiently Activates Microglia in a Transgenic Mouse Model of Amyloid Deposition J. Neurosci., July 7, 2004; 24(27): 6144 - 6151. [Abstract] [Full Text] [PDF]

				C. A. Lemere, A. Beierschmitt, M. Iglesias, E. T. Spooner, J. K. Bloom, J. F. Leverone, J. B. Zheng, T. J. Seabrook, D. Louard, D. Li, et al. Alzheimer's Disease A{beta} Vaccine Reduces Central Nervous System A{beta} Levels in a Non-Human Primate, the Caribbean Vervet Am. J. Pathol., July 1, 2004; 165(1): 283 - 297. [Abstract] [Full Text] [PDF]

				P. Das, V. Howard, N. Loosbrock, D. Dickson, M. P. Murphy, and T. E. Golde Amyloid-{beta} Immunization Effectively Reduces Amyloid Deposition in FcR{gamma}-/- Knock-Out Mice J. Neurosci., September 17, 2003; 23(24): 8532 - 8538. [Abstract] [Full Text] [PDF]

				Y. Gong, L. Chang, K. L. Viola, P. N. Lacor, M. P Lambert, C. E. Finch, G. A. Krafft, and W. L. Klein Alzheimer's disease-affected brain: Presence of oligomeric A{beta} ligands (ADDLs) suggests a molecular basis for reversible memory loss PNAS, September 2, 2003; 100(18): 10417 - 10422. [Abstract] [Full Text] [PDF]

				A. V. Terry Jr and J. J. Buccafusco The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 821 - 827. [Abstract] [Full Text] [PDF]

				J. J. Dougherty, J. Wu, and R. A. Nichols {beta}-Amyloid Regulation of Presynaptic Nicotinic Receptors in Rat Hippocampus and Neocortex J. Neurosci., July 30, 2003; 23(17): 6740 - 6747. [Abstract] [Full Text] [PDF]

				D. M. Wilcock, G. DiCarlo, D. Henderson, J. Jackson, K. Clarke, K. E. Ugen, M. N. Gordon, and D. Morgan Intracranially Administered Anti-Abeta Antibodies Reduce beta -Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation J. Neurosci., May 1, 2003; 23(9): 3745 - 3751. [Abstract] [Full Text] [PDF]

				M. L. Michaelis Drugs Targeting Alzheimer's Disease: Some Things Old and Some Things New J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 897 - 904. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help